Universal Antibody‐Engineered Lipid Nanoparticles Potentiate Chemo‐Immunotherapy Against Triple‐Negative Breast Cancer by Reprogramming Tumor Cell Metabolism

Documenti analoghi

• Metal‐Coordinated NIR‐II Nanoadjuvants with Nanobody Conjugation for Potentiating Immunotherapy by Tumor Metabolism Reprogramming
  di: Yeneng Dai, et al.
  Pubblicazione: (2024)
• Self‐assembled Lipid Nanoparticles for Killing Triple Negative Breast Cancer Cells
  di: Wahida Rahaman, et al.
  Pubblicazione: (2024)
• Co‐Delivery Evodiamine‐Porphyrin Nano‐Drug to Enhance Photodynamic‐Chemo‐Immunotherapy for Triple‐Negative Breast Cancer Treatment
  di: Qiang Zhou, et al.
  Pubblicazione: (2025)
• Dual‐Targeted Biomimetic Hybrid Nanovesicles for Tumor Microenvironment Reprogramming and Intratumoral Bacteria Eradication in Triple‐Negative Breast Cancer
  di: Maolin Li, et al.
  Pubblicazione: (2025)
• Hybrid Cell Membrane‐Coated Nanoparticles for Synergizing Sonodynamic Therapy and Immunotherapy against Triple‐Negative Breast Cancer
  di: Jiali Gong, et al.
  Pubblicazione: (2024)